Delivery Order SPE2DB22D2103-SPE2DB25FR8WC

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.13, is a delivery order for the supply of 4566947026 - TADALAFIL 5 MG TABLET 30S. It is a firm-fixed-price contract with a performance period through January 16, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4566279695 tadalafil 10 mg tablets. The firm fixed-price contract has a ceiling value of $21,250.18 and runs through October 31, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,796.93 firm fixed price delivery order covers the supply of 4566583674 - Tadalafil 20 mg Tablet 30s, with a performance period through December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,075,614 units of Tadalafil 20 mg tablets in 60-count packages, with a total ceiling value of $26,692.81. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $52,127.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,929,547 units of Tadalafil 20 mg Tablets, a medication used to treat various medical conditions. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 15, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $2,014.59 firm fixed price delivery order is for the supply of 4,564,147,104 units of the drug Tadalafil 20 mg tablets in 30-count packages. The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,742,995 Tadalafil 10 mg tablets in 30-count packages. The $10,864.44 firm-fixed price delivery order was awarded on May 29, 2024 by the Defense Logistics Agency, with a completion date of May 30, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, leverages its extensive supply chain to fulfill government contracts, particularly for the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,403.76 firm fixed-price delivery order is for the supply of 4566325359 ! TADALAFIL 5 MG TABLET 30S, with a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,381.24, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the supply of Tadalafil 20 mg tablets to support military treatment facilities, veterans' healthcare programs, and...
This federal contract award, with identification number SPE2DB20D3103|SPE2DB22FL3C1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,988.41 fixed-price delivery order is for the supply of Tadalafil 10 mg tablets, a medication used to treat various medical conditions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8WC
    Delivery Order

This federal contract award, valued at $1,392.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tadalafil 5 mg tablets in quantities of 30 tablets per bottle. This contract does not have a set-aside designation, indicating it was awarded through open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:07 AM